HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil recall complete

This article was originally published in The Tan Sheet

Executive Summary

A multiple-product recall initiated by McNeil Consumer & Specialty Pharmaceuticals was actually completed in October and is no longer "ongoing," as stated in FDA's Jan. 11 Enforcement Report (See Recalls & Court actions p. 14). The recall affected various lots of Tylenol and Motrin products rejected in the normal course of manufacturing process controls and intended for destruction under usual protocols. The listed products were stolen and "possibly diverted to retail stores" through "secondary markets" according to a McNeil spokesperson...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099008

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel